TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC

ABSTRACT: Primary Objective: To determine disease control rate (DCR) of TS-1 in patients with heavily pre-treated metastatic colorectal cancer Secondary Objectives: * To determine objective response rate (ORR) * To determine time to progression (TTP) * To determine overall survival (OS) * To assess incidence of adverse events (AEs), serious adverse events (SAEs) [Safety and Tolerability]

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2272349 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR